======= CBX4 =======
== Gene Information ==
* **Official Symbol**: CBX4
* **Official Name**: chromobox 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8535|8535]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O00257|O00257]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CBX4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CBX4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603079|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: E3 SUMO-protein ligase which facilitates SUMO1 conjugation by UBE2I (PubMed:12679040). Involved in the sumoylation of HNRNPK, a p53/TP53 transcriptional coactivator, hence indirectly regulates p53/TP53 transcriptional activation resulting in p21/CDKN1A expression. Monosumoylates ZNF131 (PubMed:22825850). {ECO:0000269|PubMed:12679040, ECO:0000269|PubMed:22825850}.
|Chromo|
|SUMO binding|
|SUMO transferase activity|
|PRC1 complex|
|PcG protein complex|
|phosphoprotein binding|
|single-stranded RNA binding|
|methylated histone binding|
|protein sumoylation|
|transcription regulatory region DNA binding|
|transcription corepressor activity|
|nuclear body|
|peptidyl-lysine modification|
|enzyme binding|
|chromatin binding|
|nuclear speck|
|chromatin organization|
|protein modification by small protein conjugation|
|negative regulation of transcription by RNA polymerase II|
|peptidyl-amino acid modification|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|protein modification by small protein conjugation or removal|
|negative regulation of cell death|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|regulation of apoptotic process|
|negative regulation of biosynthetic process|
|regulation of programmed cell death|
|regulation of cell death|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-2.56|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.01|
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.92|
|[[:results:exp539|42°C R08 exp539]]|-1.9|
|[[:results:exp211|AICAR 240μM R05 exp211]]|-1.9|
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.86|
|[[:results:exp496|Lead acetate 990μM R08 exp496]]|-1.86|
|[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.85|
|[[:results:exp189|Temozolomide 200μM R04 exp189]]|1.75|
|[[:results:exp41|BI-2536 0.001μM R01 exp41]]|1.92|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.82|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13913
* **Expression level (log2 read counts)**: 6.12
{{:chemogenomics:nalm6 dist.png?nolink |}}